Form 4: Charles River Laboratories International Director Sells Shar
Insider Transaction (Form 4)
James C Foster, a Director of Charles River Laboratories International, Inc., sold 33,561 shares of common stock on August 25, 2026 for $300.00 per share.
Summary
- Option exercise/conversion: acquired 21,132 Common Stock at $194.12 ($4,102,144) on August 25, 2026; holds 52,728 after (Direct).
- Option exercise/conversion: acquired 12,429 Common Stock at $208.44 ($2,590,701) on August 25, 2026; holds 65,157 after (Direct).
- Open-market sale: disposed of 33,561 Common Stock at $300.00 ($10,068,300) on August 25, 2026; holds 31,596 after (Direct).
- Option exercise/conversion: disposed of 21,132 Stock Options (Right to Buy) on August 25, 2026; holds 7,044 after (Direct).
- Option exercise/conversion: disposed of 12,429 Stock Options (Right to Buy) on August 25, 2026; holds 12,429 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $10,068,300 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
James C Foster — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-25 | Option exercise/conversion | Common Stock | 21,132 | $194 | $4.1M | 52,728 |
| 2026-08-25 | Option exercise/conversion | Common Stock | 12,429 | $208 | $2.6M | 65,157 |
| 2026-08-25 | Open-market sale | Common Stock | 33,561 | $300 | $10.1M | 31,596 |
| 2026-08-25 | Option exercise/conversion | Stock Options (Right to Buy) | 21,132 | — | — | 7,044 |
| 2026-08-25 | Option exercise/conversion | Stock Options (Right to Buy) | 12,429 | — | — | 12,429 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-25 | Option exercise/conversion (21,132 shares) |
| 2026-08-25 | Option exercise/conversion (12,429 shares) |
| 2026-08-25 | Open-market sale (33,561 shares) |
| 2026-08-25 | Option exercise/conversion (21,132 shares) |
| 2026-08-25 | Option exercise/conversion (12,429 shares) |
Keywords
insider transaction, Form 4, CRL, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., bearish, James C Foster
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.